Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1992 Mar;105(3):603–608. doi: 10.1111/j.1476-5381.1992.tb09026.x

Studies on the mechanism of 5-HT1 receptor-induced smooth muscle contraction in dog saphenous vein.

M J Sumner 1, W Feniuk 1, J D McCormick 1, P P Humphrey 1
PMCID: PMC1908450  PMID: 1320980

Abstract

1. We have investigated the mechanism of smooth muscle contraction evoked by activation of 5-HT1-like receptors in dog isolated saphenous vein. 2. In the presence of the 5-HT2 receptor antagonist, ritanserin (0.1 microM), concentration-effect curves (10 nM-300 microM) for 5-hydroxytryptamine (5-HT)-induced smooth muscle contraction were biphasic. This could be attributed to a direct action on 5-HT1-like receptors at low concentrations of 5-HT (10 nM-10 microM) and an indirect (through the release of noradrenaline from sympathetic neurones) activation of postjunctional alpha-adrenoceptors at higher 5-HT concentrations. In contrast, concentration-effect curves (100 nM-100 microM) for sumatriptan-induced contractions were not biphasic, and were due solely to activation of 5-HT1-like receptors. 3. Smooth muscle contractions evoked either by low concentrations of 5-HT or by sumatriptan were abolished by removal of extracellular calcium and were markedly inhibited, but not abolished, by the calcium channel blocker, verapamil (1-30 microM). In contrast, contractions evoked by high concentrations of 5-HT were markedly less sensitive to removal of extracellular calcium or to verapamil. 4. 5-HT and sumatriptan also inhibited (to a maximum of about 50%) prostaglandin E2 (PGE2, 5 microM)-stimulated adenosine 3':5'-cyclic monophosphate (cyclic AMP) formation. This effect was mimicked by the alpha 2-adrenoceptor agonist, azepexole (B-HT933) but not by the alpha 1-adrenoceptor agonist, methoxamine.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
605

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Apperley E., Feniuk W., Humphrey P. P., Levy G. P. Evidence for two types of excitatory receptor for 5-hydroxytryptamine in dog isolated vasculature. Br J Pharmacol. 1980 Feb;68(2):215–224. doi: 10.1111/j.1476-5381.1980.tb10410.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Boyer J. L., Cárdenas C., Posadas C., García-Sáinz J. A. "Pertussis toxin induces tachycardia and impairs the increase in blood pressure produced by alpha 2-adrenergic agonists". Life Sci. 1983 Dec 26;33(26):2627–2633. doi: 10.1016/0024-3205(83)90346-6. [DOI] [PubMed] [Google Scholar]
  3. Bülbring E., Tomita T. Catecholamine action on smooth muscle. Pharmacol Rev. 1987 Mar;39(1):49–96. [PubMed] [Google Scholar]
  4. Docherty J. R. The pharmacology of alpha 1- and alpha 2-adrenoceptors: evidence for and against a further subdivision. Pharmacol Ther. 1989;44(2):241–284. doi: 10.1016/0163-7258(89)90067-3. [DOI] [PubMed] [Google Scholar]
  5. Fain J. N., García-Sáinz J. A. Role of phosphatidylinositol turnover in alpha 1 and of adenylate cyclase inhibition in alpha 2 effects of catecholamines. Life Sci. 1980 Apr 14;26(15):1183–1194. doi: 10.1016/0024-3205(80)90062-4. [DOI] [PubMed] [Google Scholar]
  6. Fleckenstein A. Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle. Annu Rev Pharmacol Toxicol. 1977;17:149–166. doi: 10.1146/annurev.pa.17.040177.001053. [DOI] [PubMed] [Google Scholar]
  7. Haslam R. J., Davidson M. M., Desjardins J. V. Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP. Biochem J. 1978 Oct 15;176(1):83–95. doi: 10.1042/bj1760083. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Humphrey P. P., Feniuk W., Perren M. J., Connor H. E., Oxford A. W., Coates L. H., Butina D. GR43175, a selective agonist for the 5-HT1-like receptor in dog isolated saphenous vein. Br J Pharmacol. 1988 Aug;94(4):1123–1132. doi: 10.1111/j.1476-5381.1988.tb11630.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Humphrey P. P. The effects of alpha-adrenoceptor antagonists on contractile responses to 5-hydroxytryptamine in dog saphenous vein. Br J Pharmacol. 1978 Aug;63(4):671–675. doi: 10.1111/j.1476-5381.1978.tb17281.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kikkawa F., Furuta T., Ishikawa N., Shigei T. Different types of relationship between beta-adrenergic relaxation and activation of cyclic AMP-dependent protein kinase in canine saphenous and portal veins. Eur J Pharmacol. 1986 Sep 9;128(3):187–194. doi: 10.1016/0014-2999(86)90765-x. [DOI] [PubMed] [Google Scholar]
  11. Matthews W. D., Jim K. F., Hieble J. P., DeMarinis R. M. Postsynaptic alpha adrenoceptors on vascular smooth muscle. Fed Proc. 1984 Nov;43(14):2923–2928. [PubMed] [Google Scholar]
  12. Middlemiss D. N., Bremer M. E., Smith S. M. A pharmacological analysis of the 5-HT receptor mediating inhibition of 5-HT release in the guinea-pig frontal cortex. Eur J Pharmacol. 1988 Nov 15;157(1):101–107. doi: 10.1016/0014-2999(88)90476-1. [DOI] [PubMed] [Google Scholar]
  13. Perren M. J., Feniuk W., Humphrey P. P. Vascular 5-HT1-like receptors that mediate contraction of the dog isolated saphenous vein and carotid arterial vasoconstriction in anaesthetized dogs are not of the 5-HT1A or 5-HT1D subtype. Br J Pharmacol. 1991 Jan;102(1):191–197. doi: 10.1111/j.1476-5381.1991.tb12152.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Rasmussen H., Barrett P. Q. Calcium messenger system: an integrated view. Physiol Rev. 1984 Jul;64(3):938–984. doi: 10.1152/physrev.1984.64.3.938. [DOI] [PubMed] [Google Scholar]
  15. Resink T. J., Stucki S., Grigorian G. Y., Zschauer A., Bühler F. R. Biphasic Ca2+ response of adenylate cyclase. The role of calmodulin in its activation by Ca2+ ions. Eur J Biochem. 1986 Jan 15;154(2):451–456. doi: 10.1111/j.1432-1033.1986.tb09418.x. [DOI] [PubMed] [Google Scholar]
  16. Rhodes K. F., Waterfall J. F. The effects of some alpha-adrenoceptor antagonists on the responses of the canine saphenous vein to B-HT 933, UK-14304 and methoxamine. Naunyn Schmiedebergs Arch Pharmacol. 1987 Mar;335(3):261–268. doi: 10.1007/BF00172794. [DOI] [PubMed] [Google Scholar]
  17. Ruffolo R. R., Jr, Zeid R. L. Relationship between alpha 2-adrenoceptor occupancy and response for B-HT 933 in canine saphenous vein. Eur J Pharmacol. 1985 May 8;111(2):267–271. doi: 10.1016/0014-2999(85)90767-8. [DOI] [PubMed] [Google Scholar]
  18. Schoeffter P., Hoyer D. How selective is GR 43175? Interactions with functional 5-HT1A, 5-HT1B, 5-HT1C and 5-HT1D receptors. Naunyn Schmiedebergs Arch Pharmacol. 1989 Jul;340(1):135–138. doi: 10.1007/BF00169219. [DOI] [PubMed] [Google Scholar]
  19. Sumner M. J., Feniuk W., Humphrey P. P. Further characterization of the 5-HT receptor mediating vascular relaxation and elevation of cyclic AMP in porcine isolated vena cava. Br J Pharmacol. 1989 May;97(1):292–300. doi: 10.1111/j.1476-5381.1989.tb11953.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Sumner M. J., Humphrey P. P. Sumatriptan (GR43175) inhibits cyclic-AMP accumulation in dog isolated saphenous vein. Br J Pharmacol. 1990 Feb;99(2):219–220. doi: 10.1111/j.1476-5381.1990.tb14682.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Waeber C., Schoeffter P., Palacios J. M., Hoyer D. Molecular pharmacology of 5-HT1D recognition sites: radioligand binding studies in human, pig and calf brain membranes. Naunyn Schmiedebergs Arch Pharmacol. 1988 Jun;337(6):595–601. doi: 10.1007/BF00175783. [DOI] [PubMed] [Google Scholar]
  22. van Meel J. C., Towart R., Kazda S., Timmermans P. B., van Zwieten P. A. Correlation between the inhibitory activities of calcium entry blockers on vascular smooth muscle constriction in vitro after K+-depolarisation and in vivo after alpha 2-adrenoceptor stimulation. Naunyn Schmiedebergs Arch Pharmacol. 1983 Feb;322(1):34–37. doi: 10.1007/BF00649349. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES